Letrobol 2.5 (Letrozole USP 2.5mg) is an oral aromatase inhibitor. It works by significantly decreasing estrogen production in the body. Primarily prescribed as a breast cancer treatment, it is also utilized off-label to stimulate ovulation.
Empaworth L 25/5 MG tablet is a combination medication used to treat Type 2 diabetes mellitus in adults. It combines Empagliflozin (25 mg), an SGLT2 inhibitor that removes excess sugar via urine, with Linagliptin (5 mg), a DPP-4 inhibitor that boosts insulin release, to improve glycemic control along with diet and exercise.
| Strength | 3 mg |
| Uses | Type 2 diabetes mellitus |
| Shelf Life | 36 Months |
| Packing | Strip |
| Pack size | 1o Tablets |
| Main Igredients | Eszopiclone |